Merit Medical Systems discloses SEC inquiry into its China-based subsidiary

In a recent securities filing, Merit Medical Systems, a medical device company based in Utah, disclosed that, in January 2022, the Securities and Exchange Commission launched an inquiry into certain business activities of Merit’s China-based subsidiary.  According to the Form 10-Q filed on April 24, 2025, investigators requested the voluntary production of documents related to the activities of the China-based subsidiary, including its interactions with hospitals and health care officials in China.  Merit indicated that it was in the process of investigating the matter and is cooperating with investigators.  Merit also disclosed that it has had discussions regarding a possible resolution of the matter, although it was unable to predict the outcome of such discussions or the timing of such a resolution.

Form 10-Q